News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Theravance, Inc. to Report Second Quarter 2012 Financial Results on July 31, 2012
July 18, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SOUTH SAN FRANCISCO, Calif., July 17, 2012 (GLOBE NEWSWIRE) -- Theravance, Inc. (Nasdaq:THRX) announced today that it will release financial results for the period ended June 30, 2012 after market close on Tuesday, July 31, 2012.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Regulatory
Two FDA Decisions for Regeneron’s Eylea HD Delayed Into Q4
August 21, 2025
·
2 min read
·
Tristan Manalac
Layoffs
CSL Overhauls Business With Vaccine Spinout, 15% Layoffs
August 20, 2025
·
1 min read
·
Tristan Manalac
Podcast
MAHA Report Emphasizes Vaccines, Safety Vexes Viking’s Obesity Win, Novo Gains Momentum
August 20, 2025
·
2 min read
·
Heather McKenzie
Immuno-oncology
Genentech Walks Away From $2B Partnership With Adaptive Biotechnologies
August 19, 2025
·
1 min read
·
Tristan Manalac